Back

Watch Compare

Forte Biosciences, Inc.

Data quality: 83%

FBRX

Nasdaq Manufacturing Chemicals

$34.00

▲ $7.73 (29.43%)

Mkt Cap: 472.11 M

Price

$34.00

Mkt Cap

472.11 M

Day Range

$28.50 — $35.80

52-Week Range

$4.90 — $35.80

Volume

2,086,241

Open $29.14

50D / 200D Avg

$28.72

18.38% above

50D / 200D Avg

$18.97

79.20% above

Quick Summary

Key Takeaways

Negative free cash flow of -51.00 M

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-75.94%

Below sector avg (-53.41%)

ROIC-61.10%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio7.34

Interest Coverage-26.02

Valuation

PE (TTM)

-6.81

Below sector avg (-1.48)

P/B Ratio5.61

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-6.8	-1.5
P/B	5.6	1.6
ROE %	-75.9	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

ETFs Holding This Stock

AHSCX AHSCX

5.49% weight

AHSAX AHSAX

5.49% weight

AHSZX AHSZX

5.49% weight

ATVPX ATVPX

1.44% weight

ASCYX ASCYX

0.82% weight

ALSAX ALSAX

0.82% weight

ALSCX ALSCX

0.82% weight

AGSCX AGSCX

0.82% weight

ASCZX ASCZX

0.82% weight

AOFAX AOFAX

0.69% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-69.38 M
ROE	-75.94%	ROA	-67.73%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-51.00 M
ROIC	-61.10%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	7.34
Interest Coverage	-26.02	Asset Turnover	N/A
Working Capital	82.42 M	Tangible Book Value	84.10 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-6.81	Forward P/E	N/A
P/B Ratio	5.61	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-10.80%
Market Cap	472.11 M	Enterprise Value	378.70 M
Per Share
EPS (Diluted TTM)	-4.71	Revenue / Share	N/A
FCF / Share	-3.67	OCF / Share	-3.66
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	73.51%
SBC-Adj. FCF	-56.38 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	—	—	—	—
Net Income	-69.38 M	-35.48 M	-31.48 M	-13.88 M	-21.71 M
EPS (Diluted)	-4.71	-12.17	-1.00	-0.80	—
Gross Profit	—	—	—	—	—
Operating Income	-70.66 M	-36.60 M	-32.49 M	-13.90 M	-21.49 M
EBITDA	—	—	—	—	—
R&D Expenses	—	—	—	—	—
SG&A Expenses	—	—	—	—	—
D&A	—	—	—	—	—
Interest Expense	2.72 M	1.31 M	1.12 M	—	—
Income Tax	1.04 M	—	—	—	—

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	82.78 M	61.56 M	38.98 M	42.00 M	43.31 M
Total Liabilities	21.79 M	—	—	—	—
Shareholders' Equity	60.99 M	52.48 M	35.31 M	38.82 M	41.55 M
Total Debt	—	—	—	—	—
Cash & Equivalents	76.96 M	22.24 M	37.13 M	41.10 M	42.04 M
Current Assets	80.59 M	61.35 M	38.33 M	41.51 M	42.52 M
Current Liabilities	20.75 M	9.08 M	3.67 M	3.18 M	1.76 M